Recomendaciones para la prevención de la infección por virus respiratorio sincitial
- 1 January 2000
- journal article
- Published by Elsevier in Anales de Pediatría
- Vol. 52 (4) , 372-374
- https://doi.org/10.1016/s1695-4033(00)77360-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIVPediatrics, 1998
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1997
- Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for UsePediatrics, 1997
- Respiratory syncytial virus: a community problem.BMJ, 1979